FDCDDQ
FENC icon

Federation des caisses Desjardins du Quebec’s Fennec Pharmaceuticals FENC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36 Hold
6
– – ﹤0.01% 2928
2025
Q4 		$46 Hold
6
– – ﹤0.01% 2836
2025
Q3 		$54 Buy
+6
New +$52 ﹤0.01% 2828
2020
Q4 		– Sell
-700
Closed -$4.24K – 2345
2020
Q3 		$4.24K Buy
+700
New +$4.93K ﹤0.01% 1889
2020
Q2 		– Sell
-1
Closed -$14 – 2163
2020
Q1 		$14 Hold
1
– – ﹤0.01% 2206
2019
Q4 		$7 Hold
1
– – ﹤0.01% 2303
2019
Q3 		$5 Hold
1
– – ﹤0.01% 2270
2019
Q2 		$3 Hold
1
– – ﹤0.01% 2253
2019
Q1 		$5 Hold
1
– – ﹤0.01% 2066
2018
Q4 		$6 Hold
1
– – ﹤0.01% 2067
2018
Q3 		$8 Hold
1
– – ﹤0.01% 2125
2018
Q2 		$10 Hold
1
– – ﹤0.01% 2147
2018
Q1 		$11 Sell
1
-3
-75% -$28 ﹤0.01% 2142
2017
Q4 		$32 Hold
4
– – ﹤0.01% 2124
2017
Q3 		$43 Buy
+4
New +$46 ﹤0.01% 2072

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Federation des caisses Desjardins du Quebec's FENC Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 6 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Federation des caisses Desjardins du Quebec first reported a position in FENC in Q3 2017 and has held it in 15 quarters since. The position peaked at $4.24K in Q3 2020. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 6 shares of Fennec Pharmaceuticals worth $36 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2928 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Fennec Pharmaceuticals in Q3 2017 and has held it in 15 quarters since.
  • Federation des caisses Desjardins du Quebec's Fennec Pharmaceuticals position peaked at $4.24K in Q3 2020.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.